Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Stepan (SCL) EBT (2016 - 2025)

Stepan's EBT history spans 16 years, with the latest figure at $4.9 million for Q4 2025.

  • For Q4 2025, EBT rose 109.75% year-over-year to $4.9 million; the TTM value through Dec 2025 reached $59.9 million, up 718.47%, while the annual FY2025 figure was $59.9 million, 718.47% up from the prior year.
  • EBT reached $4.9 million in Q4 2025 per SCL's latest filing, down from $16.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $69.5 million in Q2 2022 to a low of -$75.6 million in Q4 2022.
  • Average EBT over 5 years is $17.8 million, with a median of $19.7 million recorded in 2023.
  • Peak YoY movement for EBT: tumbled 439.8% in 2022, then soared 109.75% in 2025.
  • A 5-year view of EBT shows it stood at $22.2 million in 2021, then crashed by 439.8% to -$75.6 million in 2022, then surged by 46.58% to -$40.4 million in 2023, then dropped by 25.52% to -$50.7 million in 2024, then surged by 109.75% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for SCL's EBT are $4.9 million (Q4 2025), $16.5 million (Q3 2025), and $13.8 million (Q2 2025).